MyAverix Finance
US · Healthcare
Longeveron LLC (LGVN)
Biotechnology
Longeveron LLC (LGVN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LGVN
Longeveron LLC (LGVN) — FAQ
What is LGVN's P/E ratio?
The price-to-earnings (P/E) ratio for Longeveron LLC (LGVN) is 25.00 (data as of 2026-05-23).
Does Longeveron LLC pay a dividend?
Dividend yield is not available in the current snapshot for Longeveron LLC (LGVN). Check the MyAverix Finance app for the latest dividend data.
What sector is Longeveron LLC in?
Longeveron LLC (LGVN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LGVN listed on?
LGVN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.